knowledge -WSS

knowledge

author：Wikipedia 2025-08-26 23:48:35 - browse：5

Sanofi CEO Paul Hudson Courtesy Sanofi

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

“I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： How clinical AI models' predictive power can degrade over time

focus

entertainment

WSS

A revolution in caring for preterm infants

Watch the official trailer for 'Ahsoka' series

Medicare to cover more brain scans related to Alzheimer’s drugs

Takeaways from AdvaMed, the largest medical devices conference

Grail's uphill battle for Medicare to cover its cancer screening test

Medicare to cover more brain scans related to Alzheimer’s drugs

focus

knowledge

Wikipedia

Supreme Court strikes down use of affirmative action

One Duchenne patient's bittersweet hope for new treatment

Moonlake's readout produced a cash windfall. Risks remain

Vermont grapples with historic flooding as more rainstorms head for Northeast

Medical leaders decry Supreme Court decision on affirmative action

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Psychedelics group wrestles with new pharma identity

After half a century, Israel moves to evict squatter from his cave home on the beach

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Blinken talks high

focus

European regulators consider appeal over Amylyx ALS drug

Cancer cells are shown to suck energy source from immune cells

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Bernie Sanders bashes nonprofit hospitals over their tax breaks

There’s no way to know how good AI health technologies are

One Duchenne patient's bittersweet hope for new treatment

focus

focus

entertainment

Wikipedia